A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias

Clinical trial NCT06466395 · RECRUITING

Trial details

NCT number: NCT06466395
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Acute Leukemia Relapsed Acute Leukemia Undifferentiated Leukemia Bi-Phenotypic Leukemia

Start date: 2025-02-18
Primary completion: 2027-12-31
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.